Refocus Group, Inc. is a medical device company. It engages in the business of researching and developing innovative treatments for human vision disorders, particularly for the treatment of presbyopia. The company was founded in 1994 and is headquartered in Irving, TX.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Refocus Group, Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Refocus Group, Inc. market cap is $0.00.
What is the 52-week high for Refocus Group, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Refocus Group, Inc. 52 week high is $0.00 as of September 06, 2025.
What is the 52-week low for Refocus Group, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Refocus Group, Inc. 52 week low is $0.00 as of September 06, 2025.
What is the 50-day moving average of Refocus Group, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Refocus Group, Inc. 50-day moving average is $0.00.
